A new multi-year, multi-investigator research collaboration will accelerate the translation of genomic discoveries into clinical diagnostics in oncology.
Under a new grant from the National Cancer Institute, Advanced Cell Diagnostics will partner with the Cleveland Clinic to develop an ultrasensitive diagnostic test for B-cell lymphoma.
Recent research suggests that tumor cells circulating in the blood of metastatic patients could give as accurate a genomic read-out as tumor biopsies.
Comparative Genomic Hybridization platforms from Arrayit utilize 4,000 element long-mer oligonucleotide microarrays, two-color fluorescent labeling and scanning, and single-cell amplification kits.
The P500 walk-away clinical chemistry analyzer from the Diatron Group is designed to be ergonomic and user-friendly, with a high level of automation.
NovoPath has announced the addition of an interface to Athenahealth for its Anatomic Pathology Laboratory Information System (APLIS).
A microscopic observation of drug susceptibility test kit from Hardy Diagnostics detects Mycobacterium tuberculosis while simultaneously detecting the strain’s resistance to isoniazid and rifampicin, the two most common tuberculosis antibiotics.
At the ASCP annual meeting, a panel of healthcare experts will focus on changes in the regulatory, compliance, and billing environment for pathology professionals.
The Hemoglobins Atlas from Sebia Electrophoresis includes information on common and rare genotype combinations to help laboratories using Capillarys and Minicap instruments increase their diagnostic knowledge of hemoglobinopathies.
A new line of anti-human blood protein antibodies is now available from the Binding Site, including those against human acute-phase reactants, coagulation proteins, complement, immunoglobulins, and other blood proteins such as albumin, prealbumin, and transferrin.